📊 Score Breakdown
Offering Ability
20
Cash Runway
85
Float Risk
80
Warrant Exposure
15
Convertible Debt—
🌦️ Dilution Forecast
🌥️
Advisory
Moderate dilution signals present
36%
🔄 Reverse Split
45%
• 50-day avg $1.43 approaching $1 threshold
• Only 3 months cash — financial pressure
💰 Capital Raise
35%
• Low cash runway: 3 months remaining
🔁 Convertible Conversion
15%
• Convertible debt present: 12.4% potential dilution
💹 Market Data
Market Cap$24.25M
Shares Outstanding21.46M
Float5.25M
Cash$128.9K
Debt$53.76M
Short InterestN/A
🏛 Institutional Holdings
0.0% institutional ownership
Source: Yahoo Finance · Detailed 13F holder data available for tracked tickers
📉 Short Interest
Short Interest62.7K
Days to Cover1.2
% of Float1.2%
FINRA data as of Apr 15, 2026
📁 Recent SEC Activity
xbrl
XBRL WARRANT
Dec 31, 2024
xbrl
XBRL CONVERTIBLE
Dec 31, 2024
4
INSIDER TRANSACTION
Apr 09, 2026
4
INSIDER TRANSACTION
Apr 09, 2026
4
INSIDER TRANSACTION
Apr 09, 2026
Full SEC filing analysis available with free account →
📰 Recent News
No recent news
🔬 More Research for BRLS
📊 BRLS FDA Catalyst Timeline & Biotech Grade — BiotechSigns
📡 BRLS Signal Convergence & Dark Pool Activity — StonkWhisper
Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.